Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077376
Status:
COMPLETED
Last Update Posted:
2014-05-21
First Post:
2004-02-10
Brief Title:
Trastuzumab Ixabepilone and Carboplatin in Treating Patients With HER2Neu-Positive Metastatic Breast Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Breast Cancer |
| HER2-positive Breast Cancer |
| Male Breast Cancer |
| Recurrent Breast Cancer |
Keywords: